Home » Topics » BioWorld Science

BioWorld Science
RSS

Repurposed drug promoting systemic arginine catabolism improves energy homeostasis in obese mice

Jan. 27, 2022

Chinese investigators describe AGTR2 antagonists

Jan. 27, 2022

CGeneTech identifies new CDK inhibitors

Jan. 27, 2022

Cadila Healthcare synthesizes ENPP2 inhibitors

Jan. 27, 2022

Array BioPharma discloses new HER2 inhibitors

Jan. 27, 2022

Zealand Pharma divulges LPAM-1 antagonists

Jan. 27, 2022

Discovery of novel mGlu4 receptor PAMs with antipsychotic-like properties

Jan. 27, 2022

TRAF6 loss linked to development of myeloid malignancies

Jan. 27, 2022

Exon-skipping antisense oligonucleotides show promise for treating cystic fibrosis

Jan. 27, 2022

S2K146 protects against SARS-CoV-2 infection in preclinical models

Jan. 27, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 22, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 22, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...